Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas R Cary

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|June 13, 2013
Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kineticsYuya Oguro, Douglas R Cary, Naoki Miyamoto, et al.
Journal of Medicinal Chemistry|March 31, 2017
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 InhibitorsMasahiro Ito, Toshio Tanaka, Douglas R Cary, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant InhibitorsSatoshi Sogabe, Youichi Kawakita, Shigeru Igaki, et al.
Bioorganic & Medicinal Chemistry|April 11, 2017
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potentialJun Fujimoto, Takaharu Hirayama, Yasuhiro Hirata, et al.
Organic Letters|October 2, 2020
Isostearyl Mixed Anhydrides for the Preparation of <i>N</i>-Methylated Peptides Using <i>C</i>-Terminally Unprotected <i>N</i>-Methylamino AcidsHaruaki Kurasaki, Akihiro Nagaya, Yutaka Kobayashi, et al.
Bioorganic & Medicinal Chemistry|March 18, 2017
Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivativesKoji Ono, Hiroshi Banno, Masanori Okaniwa, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the CellKyohei Hayashi, Shota Uehara, Shiho Yamamoto, et al.
Biochemical and Biophysical Research Communications|January 20, 2020
Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assaysShoichi Nakao, Masahiro Nogami, Misa Iwatani, et al.
Inorganic Chemistry|March 19, 2002
Rhenium bipyridine complexes for the recognition of glucoseDouglas R Cary, Natasha P Zaitseva, Kelsey Gray, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1<i>H</i>)-one Derivatives as Orally eIF4A3-Selective InhibitorsRyo Mizojiri, Daisuke Nakata, Yoshihiko Satoh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|June 13, 2013
Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kineticsYuya Oguro, Douglas R Cary, Naoki Miyamoto, et al.
Journal of Medicinal Chemistry|March 31, 2017
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 InhibitorsMasahiro Ito, Toshio Tanaka, Douglas R Cary, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant InhibitorsSatoshi Sogabe, Youichi Kawakita, Shigeru Igaki, et al.
Bioorganic & Medicinal Chemistry|April 11, 2017
Studies of CDK 8/19 inhibitors: Discovery of novel and selective CDK8/19 dual inhibitors and elimination of their CYP3A4 time-dependent inhibition potentialJun Fujimoto, Takaharu Hirayama, Yasuhiro Hirata, et al.
Organic Letters|October 2, 2020
Isostearyl Mixed Anhydrides for the Preparation of <i>N</i>-Methylated Peptides Using <i>C</i>-Terminally Unprotected <i>N</i>-Methylamino AcidsHaruaki Kurasaki, Akihiro Nagaya, Yutaka Kobayashi, et al.
Bioorganic & Medicinal Chemistry|March 18, 2017
Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivativesKoji Ono, Hiroshi Banno, Masanori Okaniwa, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the CellKyohei Hayashi, Shota Uehara, Shiho Yamamoto, et al.
Biochemical and Biophysical Research Communications|January 20, 2020
Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assaysShoichi Nakao, Masahiro Nogami, Misa Iwatani, et al.
Inorganic Chemistry|March 19, 2002
Rhenium bipyridine complexes for the recognition of glucoseDouglas R Cary, Natasha P Zaitseva, Kelsey Gray, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1<i>H</i>)-one Derivatives as Orally eIF4A3-Selective InhibitorsRyo Mizojiri, Daisuke Nakata, Yoshihiko Satoh, et al.
Pageof 2